United States Uterine Cancer Market Size & Outlook, 2025-2033


United States Uterine Cancer Market Insights

  • Reed Intelligence analysis indicates that the United States Uterine Cancer Market size, valued at USD 1373.41 Million in 2024, is expected to expand to USD 2085.43 Million by 2033.
  • The United States market is forecasted to expand at a CAGR of 4.83% spanning 2026–2033.
  • Endometrial Adenocarcinoma held the leading position among By Type segments in 2024, based on market size.
  • Uterine Sarcoma is projected to post the fastest growth rate, sustaining its position as the most attractive By Type segment during the forecast horizon.

Other Key Findings


  • United States accounted for 21.94% of the global Uterine Cancer Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within North America, United States is forecasted to dominate the regional Uterine Cancer Market size by 2033.
  • United States will be the fastest-growing market in North America, projected to achieve USD 2099.76 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 1373.41 Million
Market Size In 2033 USD 2085.43 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 4.83% (2025-2033)
Segmnetation Covered
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends